tazobactam has been researched along with Kidney Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bidell, MR; Lodise, TP | 1 |
| Akers, KS; Cannon, JW; Chung, KK; Cota, JM; Murray, CK; Niece, KL | 1 |
| Guillaume, Y; Guinchard, C; Peyrin, E | 1 |
| Dalla Costa, T; Derendorf, H | 1 |
| de la Pena, A; Derendorf, H | 1 |
| Amorusi, P; Dowell, JA; Korth-Bradley, J; Milisci, M; Tantillo, K; Tse, S | 1 |
| Dutta, A; Faulkner, R; Greene, DS; Halstenson, CE; Haynes, J; Johnson, CA; Kelloway, JS; Shapiro, BE; Tonelli, A; Zimmerman, SW | 1 |
2 review(s) available for tazobactam and Kidney Diseases
| Article | Year |
|---|---|
Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Drug Combinations; Glomerular Filtration Rate; Humans; Kidney Diseases; Tazobactam; Treatment Outcome | 2018 |
Pharmacokinetic properties of beta-lactamase inhibitors.
Topics: Absorption; Aging; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Biological Availability; Clavulanic Acid; Drug Synergism; Enzyme Inhibitors; Half-Life; Humans; Kidney Diseases; Penicillanic Acid; Sulbactam; Tazobactam | 1999 |
1 trial(s) available for tazobactam and Kidney Diseases
| Article | Year |
|---|---|
Evaluating possible pharmacokinetic interactions between tobramycin, piperacillin, and a combination of piperacillin and tazobactam in patients with various degrees of renal impairment.
Topics: Adult; Aged; Aging; Anti-Bacterial Agents; Area Under Curve; beta-Lactamase Inhibitors; Creatinine; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Tobramycin | 2001 |
4 other study(ies) available for tazobactam and Kidney Diseases
| Article | Year |
|---|---|
Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Critical Illness; Cross-Sectional Studies; Female; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Wounds and Injuries; Young Adult | 2014 |
High-performance liquid chromatographic determination of tazobactam by precolumn derivatization.
Topics: beta-Lactamase Inhibitors; Calibration; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Hemofiltration; Humans; Indicators and Reagents; Kidney Diseases; Penicillanic Acid; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tazobactam | 1995 |
Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairment.
Topics: Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Half-Life; Humans; Kidney Diseases; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 1996 |
Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease.
Topics: Adult; beta-Lactamase Inhibitors; Creatine; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Penicillanic Acid; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Renal Dialysis; Tazobactam; Time Factors | 1992 |